KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Interest & Investment Income: 2014-2017

Historic Interest & Investment Income for TherapeuticsMD (TXMD) over the last 1 years, with Jun 2017 value amounting to $3,867.

  • TherapeuticsMD's Interest & Investment Income rose 35.07% to $3,867 in Q2 2017 from the same period last year, while for Jun 2017 it was $42,236, marking a year-over-year increase of 2.69%. This contributed to the annual value of $10,824 for FY2016, which is 37.94% down from last year.
  • TherapeuticsMD's Interest & Investment Income amounted to $3,867 in Q2 2017, which was up 35.07% from $2,863 recorded in Q2 2016.
  • In the past 5 years, TherapeuticsMD's Interest & Investment Income registered a high of $41,617 during Q1 2016, and its lowest value of -$6,111 during Q4 2015.
  • Its 3-year average for Interest & Investment Income is $10,585, with a median of $3,365 in 2016.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first crashed by 163.97% in 2015, then skyrocketed by 124.80% in 2016.
  • TherapeuticsMD's Interest & Investment Income (Quarterly) stood at $9,553 in 2014, then crashed by 163.97% to -$6,111 in 2015, then soared by 124.80% to $2,863 in 2016, then surged by 35.07% to $3,867 in 2017.
  • Its last three reported values are $3,867 in Q2 2017, $2,863 for Q2 2016, and $41,617 during Q1 2016.